17 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Viveve Medical, Inc. VIVE shares moved upwards by 114.5% to $8.15 during Wednesday's pre-market session. The market cap seems to be at $2.6 million. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
• Achillion Pharmaceuticals, Inc. ACHN shares rose 84.4% to $6.73. The market value of their outstanding shares is at $503.5 million.
• Xenetic Biosciences, Inc. XBIO stock increased by 50.0% to $1.62. The market cap seems to be at $6.5 million.
• Trinity Biotech, Inc. TRIB shares moved upwards by 22.4% to $1.20. The market cap seems to be at $28.8 million.
• Ocugen, Inc. OCGN stock rose 17.0% to $1.79. The market cap stands at $4.4 million.
• Mallinckrodt, Inc. MNK shares rose 5.8% to $2.20. The market cap seems to be at $202.4 million. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
• Teva Pharmaceutical Indus, Inc. TEVA shares rose 3.5% to $7.20. The most recent rating by Wells Fargo, on September 30, is at Market Perform, with a price target of $8.00.
• DBV Technologies, Inc. DBVT shares moved upwards by 2.9% to $7.85.
• Aurora Cannabis, Inc. ACB stock increased by 1.1% to $3.79. The market cap stands at $6.3 billion. The most recent rating by MKM Partners, on September 20, is at Sell, with a price target of $5.00.
• Johnson & Johnson, Inc. JNJ stock rose 1.1% to $134.25. The market value of their outstanding shares is at $347.1 billion. According to the most recent rating by Atlantic Equities, on October 16, the current rating is at Neutral.

Losers

• Titan Pharmaceuticals, Inc. TTNP stock plummeted 18.4% to $0.30 during Wednesday's pre-market session. The market cap seems to be at $4.2 million.
• Rhythm Pharmaceuticals, Inc. RYTM shares declined 11.3% to $18.53. The market cap stands at $821.1 million.
• ProQR Therapeutics, Inc. PRQR stock declined 11.2% to $5.52. The market value of their outstanding shares is at $238.9 million.
• Plus Therapeutics, Inc. PSTV shares declined 5.5% to $2.60. The market value of their outstanding shares is at $1.5 million.
• Principia Biopharma, Inc. PRNB shares declined 5.4% to $28.30. The market value of their outstanding shares is at $740.9 million.
• Abbott Laboratories, Inc. ABT stock decreased by 2.5% to $80.00. The market cap stands at $145.7 billion. The most recent rating by Raymond James, on October 14, is at Outperform, with a price target of $90.00.
• Eli Lilly, Inc. LLY stock fell 1.6% to $108.00. The market cap seems to be at $109.3 billion. The most recent rating by Bank of America, on September 10, is at Neutral, with a price target of $120.00.